Specifically, Table 1 showcases theImmunohistochemical panel positivity in Wilms tumor, highlighting markers such as WT1 (Wilms tumor 1), PAX8 (Paired-box gene-8), and BCL2 (B-cell lymphoma 2).In a similar vein, Table 2 illustrates the IHC panel positivity in Rhabdomyosarcoma, indicating markers like SMA(Smooth Muscle Actin). This evidence concerns the gene BCL2 and rhabdomyosarcoma.